Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's Pazdur To Patient Advocates: Focus On Issues That 'Drive The Show'

This article was originally published in The Pink Sheet Daily

Executive Summary

Agency's oncology office director reflects on his wife's experience with cancer and urges patient community to tackle 'big picture issues' like clinical trial eligibility and informed consent.

Advertisement

Related Content

Cancer Drug Trials Could Benefit From ‘Rational’ Eligibility Criteria
Cancer Trials: Broader Eligibility Criteria Could Mean Novel Labeling Claims

Topics

Advertisement
UsernamePublicRestriction

Register

PS078001

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel